Real-time enrollment status for this pulmonary arterial hypertension pah clinical trial
Current Status
Recruiting
Checked: September 3, 2026 at 1:01 AM UTC
| NCT Number | NCT05967299 |
| Recruiting Status | Recruiting |
| Condition | Pulmonary Arterial Hypertension PAH |
| Phase | PHASE1 |
| Target Enrollment | 96 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Heart, Lung, and Blood Institute (NHLBI) |
| Last Updated on CT.gov | June 5, 2026 (Jun 5, 2026) |
As of September 3, 2026: Clinical trial NCT05967299 is currently recruiting participants. This phase1 study for pulmonary arterial hypertension pah is actively seeking new participants at 1 location across the United States. The study is sponsored by National Heart, Lung, and Blood Institute (NHLBI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05967299 is actively recruiting participants as of September 3, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05967299 was last updated Jun 5, 2026 (June 5, 2026). HelloStudys verifies this status automatically.